SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 426
Posts 23,040
Boards Moderated 5
Alias Born 09/11/06
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/9/2017 4:33:26 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 11/9/2017 4:06:32 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2017 6:05:26 AM
Supernus to Present at Three November Healthcare Conferences "GlobeNewswire Inc." - 11/8/2017 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 6:05:08 AM
Supernus Announces Third Quarter 2017 Financial Results "GlobeNewswire Inc." - 11/6/2017 5:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2017 4:50:15 PM
Supernus to Host Third Quarter 2017 Earnings Conference Call "GlobeNewswire Inc." - 10/24/2017 4:15:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/20/2017 4:38:48 PM
Supernus Provides Update on SPN-810 Phase III Clinical Trials "GlobeNewswire Inc." - 9/18/2017 4:04:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2017 7:24:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2017 7:24:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2017 7:23:40 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/17/2017 4:48:56 PM
Supernus Defeats Second Generic Challenger to Oxtellar XR® "GlobeNewswire Inc." - 8/15/2017 4:45:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/3/2017 3:51:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 4:58:53 PM
Supernus Announces Record Second Quarter 2017 Financial Results "GlobeNewswire Inc." - 8/2/2017 4:15:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 4:09:10 PM
Supernus to Host Second Quarter 2017 Earnings Conference Call "GlobeNewswire Inc." - 7/19/2017 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/14/2017 4:25:21 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 6/30/2017 11:24:52 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/27/2017 4:28:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/23/2017 4:42:25 PM
Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD "GlobeNewswire Inc." - 6/21/2017 12:37:14 PM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 129 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo



surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist